FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1274431000168104: lanadelumab (AU substance)

Status: current, Primitive. Date: 31-Mar 2019. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3262481000168114 lanadelumab (AU substance) en Fully specified name Active Case sensitive Australian Medicines Terminology module
3262491000168112 lanadelumab en Synonym Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
lanadelumab Is a medicinal substance true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
lanadelumab has intended active ingredient True lanadelumab Inferred relationship Some 1
lanadelumab 300 mg/2 mL injection, vial has Australian BoSS True lanadelumab Inferred relationship Some 1868607342
lanadelumab 300 mg/2 mL injection, vial has intended active ingredient True lanadelumab Inferred relationship Some 1868607342
Takhzyro 300 mg/2 mL injection, 2 mL vial has Australian BoSS True lanadelumab Inferred relationship Some 930210254
Takhzyro 300 mg/2 mL injection, 2 mL vial has intended active ingredient True lanadelumab Inferred relationship Some 930210254
Takhzyro 300 mg/2 mL injection, 2 mL syringe has Australian BoSS True lanadelumab Inferred relationship Some 1698216351
Takhzyro 300 mg/2 mL injection, 2 mL syringe has intended active ingredient True lanadelumab Inferred relationship Some 1698216351
lanadelumab 300 mg/2 mL injection, syringe has Australian BoSS True lanadelumab Inferred relationship Some 1892667559
lanadelumab 300 mg/2 mL injection, syringe has intended active ingredient True lanadelumab Inferred relationship Some 1892667559

This concept is not in any reference sets

Back to Start